<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Acne Vulgaris ‚Äì Primary Care Algorithm (‚â•12y)</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
  <style>
    :root{
      --bg: #0b0c10;
      --panel: #111319;
      --ink: #e9ecf1;
      --muted: #a9b0bc;
      --accent: #4f8cff;
      --accent-2: #7dd3fc;
      --warn: #f59e0b;
      --danger: #ef4444;
      --ok: #22c55e;
      --chip: #1b1f2a;
    }
    @media (prefers-color-scheme: light){
      :root{
        --bg: #f6f7fb;
        --panel: #ffffff;
        --ink: #111827;
        --muted: #475569;
        --accent: #2563eb;
        --accent-2: #0284c7;
        --warn: #b45309;
        --danger: #b91c1c;
        --ok: #15803d;
        --chip: #eef2ff;
      }
    }
    html,body{height:100%}
    body{
      margin:0; font-family:Inter, system-ui, -apple-system, Segoe UI, Roboto, sans-serif;
      background: radial-gradient(1200px 800px at 80% -10%, rgba(79,140,255,.15), transparent 60%), var(--bg);
      color:var(--ink);
      -webkit-font-smoothing: antialiased; text-rendering: optimizeLegibility;
    }
    .container{max-width:1100px; margin:0 auto; padding:24px;}
    header{
      display:flex; align-items:center; justify-content:space-between; gap:16px; flex-wrap:wrap;
      margin-bottom:18px;
    }
    .brand{display:flex; gap:12px; align-items:center}
    .logo{width:40px; height:40px; border-radius:12px; background:linear-gradient(135deg, var(--accent), var(--accent-2)); display:grid; place-items:center; color:white; font-weight:800}
    h1{font-size: clamp(1.4rem, 2.6vw, 2rem); margin:0; letter-spacing:.2px}
    .sub{color:var(--muted); font-size:.95rem}
    .toolbar{display:flex; gap:8px; flex-wrap:wrap}
    .btn{border:1px solid color-mix(in srgb, var(--ink) 12%, transparent); background:color-mix(in srgb, var(--panel) 85%, var(--accent) 15% / 5%); color:var(--ink); padding:10px 14px; border-radius:12px; font-weight:600; cursor:pointer}
    .btn:hover{border-color: color-mix(in srgb, var(--accent) 40%, transparent); box-shadow:0 6px 18px rgba(0,0,0,.12)}
    .grid{display:grid; grid-template-columns: 1.15fr .85fr; gap:18px}
    @media (max-width: 980px){ .grid{grid-template-columns:1fr} }
    .card{background:var(--panel); border-radius:16px; padding:18px 18px; border: 1px solid color-mix(in srgb, var(--ink) 10%, transparent); box-shadow: 0 10px 20px rgba(0,0,0,.1)}
    .card h2{margin:.2rem 0 .6rem; font-size: clamp(1.05rem,1.5vw,1.25rem)}
    .card h3{margin:1.0rem 0 .4rem; font-size:1rem; color:var(--muted); text-transform:uppercase; letter-spacing:.12em}
    .card p, .card li{line-height:1.6}
    .chip{display:inline-flex; align-items:center; gap:6px; font-weight:600; font-size:.85rem; background:var(--chip); color:var(--ink); padding:6px 10px; border-radius:999px; border:1px solid color-mix(in srgb, var(--ink) 12%, transparent)}
    .row{display:flex; flex-wrap:wrap; gap:8px}
    .kpi{display:grid; grid-template-columns:auto 1fr; gap:10px; align-items:flex-start; padding:12px; background:linear-gradient(180deg, color-mix(in srgb, var(--panel) 80%, var(--accent) 20% / 10%), var(--panel)); border:1px dashed color-mix(in srgb, var(--accent) 40%, transparent); border-radius:14px}
    .kpi .icon{width:24px; height:24px}
    .list{padding-left:1.1rem}
    .list li{margin:.28rem 0}
    .pill{display:inline-block; padding:4px 8px; border-radius:8px; font-weight:700; font-size:.8rem; letter-spacing:.02em}
    .pill-ok{background: #022c22; color:#34d399; border:1px solid #065f46}
    .pill-no{background: #2f0b0b; color:#fca5a5; border:1px solid #7f1d1d}
    .split{display:grid; grid-template-columns:1fr 1fr; gap:12px}
    @media (max-width:680px){ .split{grid-template-columns:1fr} }
    .callout{border-left:4px solid var(--accent); padding:10px 12px; background:color-mix(in srgb, var(--panel) 85%, var(--accent) 15% / 10%); border-radius:8px}
    .ref{color:var(--muted); font-size:.85rem}
    .footer{margin-top:16px; color:var(--muted); font-size:.86rem}

    /* Stepper */
    .stepper{display:grid; grid-template-columns: 28px 1fr; gap:10px}
    .step{position:relative; padding-bottom:14px}
    .dot{width:28px; height:28px; border-radius:999px; background:linear-gradient(135deg, var(--accent), var(--accent-2)); color:white; display:grid; place-items:center; font-weight:800}
    .line{position:absolute; left:13px; top:32px; bottom:-4px; width:2px; background:linear-gradient(to bottom, color-mix(in srgb, var(--accent) 30%, transparent), color-mix(in srgb, var(--ink) 22%, transparent))}

    /* Print styles: condense to single page */
    @media print{
      body{background:white}
      .container{max-width:100%; padding:0}
      header{margin:0 0 4mm}
      .toolbar{display:none}
      .grid{grid-template-columns:1fr 1fr; gap:8mm}
      .card{page-break-inside: avoid; box-shadow:none; border:1pt solid #d0d7de}
      .footer{margin-top:4mm}
    }
  </style>
</head>
<body>
  <div class="container">
    <header>
      <div class="brand">
        <div class="logo" aria-hidden="true">AV</div>
        <div>
          <h1>Acne Vulgaris ‚Äî Primary Care Algorithm (‚â•12 years)</h1>
          <div class="sub">Fast reference for assessment, treatment, review, referral, and relapse management.</div>
        </div>
      </div>
      <div class="toolbar">
        <button class="btn" onclick="window.print()" title="Print or save as PDF">üñ®Ô∏è Print / Save PDF</button>
      </div>
    </header>

    <div class="grid">
      <!-- Left column -->
      <section class="card">
        <div class="row" style="margin-bottom:10px">
          <span class="chip">NICE CKS aligned ‚Ä¢ Nov¬†2023</span>
          <span class="chip">Antibiotic stewardship</span>
          <span class="chip">One-page view</span>
        </div>

        <h2>1) Initial Assessment</h2>
        <div class="stepper" aria-label="Initial assessment steps">
          <div class="step">
            <div class="dot">1</div>
            <div class="line"></div>
          </div>
          <div>
            <p><strong>Confirm diagnosis</strong> (comedones present). Exclude rosacea, periorificial dermatitis, folliculitis/boils, drug-induced acne, keratosis pilaris. Note distribution: face, chest, back.</p>
          </div>

          <div class="step">
            <div class="dot">2</div>
            <div class="line"></div>
          </div>
          <div>
            <p><strong>Grade severity</strong>: <em>Mild‚ÄìModerate</em> (comedones ¬± papules/pustules) vs <em>Moderate‚ÄìSevere</em> (widespread papules/pustules ¬± nodules/cysts; scarring may be present).</p>
          </div>

          <div class="step">
            <div class="dot">3</div>
            <div class="line"></div>
          </div>
          <div>
            <p><strong>Screen</strong> for scarring, pigmentary change, psychosocial impact, systemic comorbidities, endocrine features (e.g., PCOS), and acne aggravating meds (androgens, steroids, lithium, some antiepileptics, isoniazid, ciclosporin, vitamins B1/6/12).</p>
          </div>

          <div class="step">
            <div class="dot">4</div>
            <div class="line"></div>
          </div>
          <div>
            <p><strong>Childbearing potential?</strong> Discuss contraception and <span class="pill pill-no">avoid topical retinoids & tetracyclines in pregnancy/planning</span>.</p>
          </div>
        </div>

        <h2>2) First‚Äëline Treatment (12¬†weeks)</h2>
        <div class="split">
          <div>
            <h3>Mild‚ÄìModerate</h3>
            <ul class="list">
              <li>Use <strong>one fixed topical combo (OD, evening)</strong>:
                <ul class="list">
                  <li>Adapalene <em>+</em> benzoyl peroxide</li>
                  <li>Tretinoin <em>+</em> clindamycin</li>
                  <li>Benzoyl peroxide <em>+</em> clindamycin</li>
                </ul>
              </li>
              <li><strong>Alternative:</strong> benzoyl peroxide monotherapy (if avoiding retinoid/antibiotic).</li>
              <li>Choose vehicle by skin type; titrate frequency/strength for irritation.</li>
            </ul>
          </div>
          <div>
            <h3>Moderate‚ÄìSevere</h3>
            <ul class="list">
              <li>Topical combo (as left) <strong>+</strong> <em>one</em> oral antibiotic:
                <ul class="list">
                  <li>Lymecycline 408¬†mg OD <strong>or</strong> doxycycline 100¬†mg OD</li>
                </ul>
              </li>
              <li><strong>Alternative:</strong> azelaic acid (15‚Äì20%, BD) <strong>+</strong> an oral antibiotic.</li>
              <li><strong>If tetracyclines unsuitable:</strong> consider trimethoprim or a macrolide (e.g., erythromycin).</li>
              <li><strong>Women:</strong> consider a combined oral contraceptive with topical agents as an alternative to systemic antibiotics (avoid progestin‚Äëonly with androgenic activity).</li>
            </ul>
          </div>
        </div>

        <div class="kpi" style="margin-top:10px" role="note" aria-label="Important do not use list">
          <svg class="icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><circle cx="12" cy="12" r="10"></circle><line x1="15" y1="9" x2="9" y2="15"></line></svg>
          <div>
            <strong>Do <em>not</em> use:</strong> topical antibiotic monotherapy; oral antibiotic monotherapy; or topical <em>plus</em> oral antibiotic combinations.
          </div>
        </div>

        <h2>3) Review at 12¬†Weeks</h2>
        <ul class="list">
          <li><strong>Cleared (on oral abx)</strong> ‚Üí stop oral abx; continue topical.</li>
          <li><strong>Improved, not cleared</strong> ‚Üí continue oral abx + topical up to <em>another</em> 12¬†weeks.</li>
          <li><strong>No/poor response:</strong>
            <ul class="list">
              <li><em>Mild‚ÄìModerate</em> ‚Üí switch to a different first‚Äëline option.</li>
              <li><em>Moderate‚ÄìSevere</em> ‚Üí if no oral abx yet, add one; if already used, <strong>refer</strong>.</li>
            </ul>
          </li>
          <li><span class="pill pill-no">Avoid >6¬†months of antibiotics</span> except exceptional cases; 3‚Äëmonthly reviews and stop ASAP.</li>
        </ul>

        <h2>4) Maintenance & Relapse</h2>
        <div class="split">
          <div>
            <h3>Maintenance (if frequent relapse)</h3>
            <ul class="list">
              <li>Preferred: <strong>adapalene + benzoyl peroxide</strong>.</li>
              <li>Alternatives: adapalene 0.1%, azelaic acid 15‚Äì20%, benzoyl peroxide 5%.</li>
              <li>Review at 12¬†weeks to decide continuation.</li>
            </ul>
          </div>
          <div>
            <h3>Relapse pathway</h3>
            <ul class="list">
              <li>After prior success ‚Üí repeat same 12‚Äëweek regimen <em>or</em> alternative.
              </li>
              <li>Post‚Äëisotretinoin relapse:
                <ul class="list">
                  <li>Mild‚ÄìModerate ‚Üí treat as above in primary care.</li>
                  <li>Moderate‚ÄìSevere ‚Üí 12‚Äëweek option or <strong>re‚Äërefer</strong> to dermatology.</li>
                </ul>
              </li>
            </ul>
          </div>
        </div>
      </section>

      <!-- Right column -->
      <aside class="card">
        <h2>5) Referral Criteria</h2>
        <ul class="list">
          <li><strong>Urgent (same day):</strong> acne fulminans (hospital dermatology on‚Äëcall; assess within 24¬†h).</li>
          <li><strong>Routine to dermatologist‚Äëled team:</strong>
            <ul class="list">
              <li>Diagnostic uncertainty.</li>
              <li>Acne conglobata or nodulocystic acne.</li>
              <li>Moderate‚ÄìSevere unresponsive to appropriate oral antibiotic.</li>
              <li>‚â•2 completed 12‚Äëweek courses without adequate response (any severity).</li>
              <li>Scarring or persistent pigmentary change.</li>
              <li>Significant psychological distress / mental health disorder.</li>
            </ul>
          </li>
        </ul>

        <h2>6) Patient Advice (at every start/switch)</h2>
        <ul class="list">
          <li>Improvement usually visible in <strong>6‚Äì8¬†weeks</strong>.</li>
          <li>Expect early irritation; start <em>alternate days</em> or <em>short‚Äëcontact</em> use, then build to daily.</li>
          <li>Avoid over‚Äëcleansing; use non‚Äëalkaline synthetic detergent cleanser twice daily.</li>
          <li>Non‚Äëcomedogenic skincare/makeup; remove makeup nightly; avoid oil‚Äëbased sunscreens.</li>
          <li>Picking/scratching increases scarring risk.</li>
          <li>Healthy diet advice; insufficient evidence for specific acne diets.</li>
        </ul>

        <h2>7) Special Notes</h2>
        <div class="callout">
          <p><strong>Pregnancy/Planning:</strong> <span class="pill pill-no">Avoid topical retinoids</span> and <span class="pill pill-no">avoid tetracyclines</span>. Use effective contraception if using these agents.</p>
          <p><strong>If isotretinoin considered (specialist‚Äëinitiated):</strong> discuss benefits/risks, mental health/sexual function monitoring, pregnancy prevention program and documentation; under‚Äë18s require <em>two</em> clinicians to confirm no other effective option.</p>
        </div>

        <h3 style="margin-top:14px">Quick Vehicle & Tolerability Tips</h3>
        <ul class="list">
          <li>Creams/lotions for dry/sensitive skin; gels for oily skin.</li>
          <li>Use moisturizer and sunscreen to improve tolerability of retinoids/benzoyl peroxide.</li>
          <li>Benzoyl peroxide may bleach fabrics/hair; increase sun sensitivity.</li>
        </ul>

        <div class="footer">
          <div class="ref">Source: NICE Clinical Knowledge Summaries (CKS) ‚Äì Acne vulgaris (last revised Nov¬†2023). This page condenses the guidance for rapid clinical reference.</div>
        </div>
      </aside>
    </div>
  </div>
</body>
</html>
